Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The selective 5-HT1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress
Monika Głuch‐Lutwin, Kinga Sałaciak, Alicja Gawalska, et al.
Psychopharmacology (2021) Vol. 238, Iss. 8, pp. 2249-2260
Open Access | Times Cited: 17

Showing 17 citing articles:

Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders
Adrian Newman‐Tancredi, Ronan Depoortère, Mark S. Kleven, et al.
Pharmacology & Therapeutics (2021) Vol. 229, pp. 107937-107937
Closed Access | Times Cited: 55
Biased agonism in drug discovery: Is there a future for biased 5-HT1A receptor agonists in the treatment of neuropsychiatric diseases?
Kinga Sałaciak, Karolina Pytka
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107872-107872
Open Access | Times Cited: 35
Novel Molecular Targets of Antidepressants
Małgorzata Jarończyk, Jarosław Walory
Molecules (2022) Vol. 27, Iss. 2, pp. 533-533
Open Access | Times Cited: 25
Rapid reorganization of serotonin projections and antidepressant response to 5-HT1A-biased agonist NLX-101 in fluoxetine-resistant cF1ko mice.
Faranak Vahid-Ansari, Adrian Newman‐Tancredi, Alberto Francisco Fuentes-Alvarenga, et al.
Neuropharmacology (2024) Vol. 261, pp. 110132-110132
Open Access | Times Cited: 4
Rescue of respiratory and cognitive impairments in Rett Syndrome mice using NLX-101, a selective 5-HT1A receptor biased agonist
Daniela Monteiro-Fernandes, Ian Charles, Sara Guerreiro, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 117989-117989
Closed Access
Discovery of NLX-266, an Orally Available and Metabolically Stable ERK1/2-Biased 5-HT1AR Agonist with Superior Antidepressant and Antiparkinsonian Activity
Joanna Śniecikowska, Monika Głuch‐Lutwin, Adam Bucki, et al.
Journal of Medicinal Chemistry (2025)
Open Access
The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, display ketamine-like RAAD and anti-TRD activities in rat CMS models
Mariusz Papp, Piotr Gruca, Magdalena Łasoń, et al.
Psychopharmacology (2023) Vol. 240, Iss. 11, pp. 2419-2433
Open Access | Times Cited: 9
Progress on the development of Class A GPCR‐biased ligands
Paula Morales, Magdalena M. Scharf, Marcel Bermúdez, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3
New investigational agents for the treatment of major depressive disorder
Bartłomiej Pochwat, Anna Julia Krupa, Marcin Siwek, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 10, pp. 1053-1066
Closed Access | Times Cited: 13
Molecular Signaling Mechanisms for the Antidepressant Effects of NLX-101, a Selective Cortical 5-HT1A Receptor Biased Agonist
Sharon Cabanu, Fuencisla Pilar-Cuéllar, Paula Zubakina, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 337-337
Open Access | Times Cited: 9
Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors
Hualong Fu, Jian Rong, Zhen Chen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 16, pp. 10755-10808
Closed Access | Times Cited: 8
Understanding the Molecular Regulation of Serotonin Receptor 5-HTR1B-β-Arrestin1 Complex in Stress and Anxiety Disorders
Oindrilla Dutta Gupta, Izhar Karbat, Kuntal Pal
Journal of Molecular Neuroscience (2023) Vol. 73, Iss. 7-8, pp. 664-677
Closed Access | Times Cited: 4
Dissecting the contribution of 5-HT1A auto- and heteroreceptors in sucrose overconsumption in mice
Kate Beecher, Joshua Wang, Fatemeh Chehrehasa, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112699-112699
Open Access | Times Cited: 5
The selective 5-HT1A receptor agonist NLX-112 displays anxiolytic-like activity in mice
William Powell, Lucy E. Annett, Ronan Depoortère, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 395, Iss. 2, pp. 149-157
Closed Access | Times Cited: 6
The 5-HT1A receptor biased agonist, NLX-204, shows rapid-acting antidepressant-like properties and neurochemical changes in two mouse models of depression
Monika Głuch‐Lutwin, Kinga Sałaciak, Karolina Pytka, et al.
Behavioural Brain Research (2022) Vol. 438, pp. 114207-114207
Closed Access | Times Cited: 4
May the SSRIs play a role in the onset of peri- and post-menopausal cervical cancer?
Ciro Gargiulo Isacco, Raffaele Del Prete, Pietro Distratis, et al.
Deleted Journal (2024) Vol. 6, Iss. 7
Open Access
Serotonin 5-HT1A receptor biased agonists: the challenge of translating an innovative neuropharmacological concept into therapeutics
Luc Zimmer, Adrian Newman‐Tancredi
Neuropharmacology (2024) Vol. 265, pp. 110267-110267
Closed Access
Page 1

Scroll to top